Vaccine COVID-19 will not be in the US until November, it just doesn’t have time to officially register drugs that are being developed in the country. This opinion was expressed by head of the National Institute of health Francis Collins, writes Reuters.
“a Potential vaccine for coronavirus will receive approval from regulators not earlier than in November-December. This is due to conduct large-scale clinical trials,” – with reference to the source TASS.
Earlier, the President said that as soon as obtained all necessary approvals from specialists in the U.S. produce about 600 million doses of vaccine. According to the Johns Hopkins University, which maintains statistics on the incidence of coronavirus, a positive test for infection received 5 million 244 thousand 238 people in the country. Add that the development of drugs against the coronavirus was addressed by several pharmaceutical companies, including AstraZeneca, Moderna, Johnson & Johnson.
About check the world’s first vaccine against the coronavirus SARS-CoV-2 announced in Russia on Tuesday, 11 August. The drug was developed by the experts of the National research centre of epidemiology and Microbiology named after N. F. Gamalei.
